| Newborn screening for Tyr-I: Two years' experience of the New York State program. | |
| | |
MedLine Citation:
|
PMID: 21441051 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
In 2years, the New York newborn screening program has analyzed approximately 500,000 samples for succinylacetone (SUAC), the biomarker for Tyrosinemia, type I. There have been five screen-positive results. Two of these results were considered borderline, and a repeat specimen was requested. In three cases, an immediate referral was made to a specialty care center. Two of those three cases were confirmed for Tyr-I. |
| | |
Authors:
|
M A Morrissey; S Sunny; A Fahim; C Lubowski; M Caggana |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-3-1 |
Journal Detail:
|
Title: Molecular genetics and metabolism Volume: - ISSN: 1096-7206 ISO Abbreviation: - Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-3-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9805456 Medline TA: Mol Genet Metab Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Elsevier Inc. All rights reserved. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Modification of Martini force field for molecular dynamics simulation of hydrophobic charge inductio...
Next Document: Oxytocin and bone remodelling: Relationships with neuropituitary hormones, bone status and body comp...